113 related articles for article (PubMed ID: 27975193)
1. Inhibition of Glomerular Mesangial Cell Proliferation by siPDGF-B- and siPDGFR-β-Containing Chitosan Nanoplexes.
Salva E; Turan SÖ; Akbuğa J
AAPS PharmSciTech; 2017 May; 18(4):1031-1042. PubMed ID: 27975193
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of chitosan-mediated silencing of PDGF-B and PDGFR-β in the mesangial proliferative glomerulonephritis therapy.
Alan S; Şalva E; Yılmaz İ; Turan SÖ; Akbuğa J
Exp Mol Pathol; 2019 Oct; 110():104280. PubMed ID: 31265815
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with chitosan/siRNA nanoplexes targeting PDGF-D and PDGFR-β reveals anticancer effect in breast cancer.
Şalva E; Özbaş S; Alan S; Özkan N; Ekentok-Atıcı C; Kabasakal L; Akbuğa J
J Gene Med; 2023 Feb; 25(2):e3465. PubMed ID: 36413571
[TBL] [Abstract][Full Text] [Related]
4. Chitosan nanoparticle carrying small interfering RNA to platelet-derived growth factor B mRNA inhibits proliferation of smooth muscle cells in rabbit injured arteries.
Xia H; Jun J; Wen-Ping L; Yi-Feng P; Xiao-Ling C
Vascular; 2013 Oct; 21(5):301-6. PubMed ID: 23518855
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolic acid inhibits the autocrine PDGF-B synthesis and PDGF-BB-induced mRNA expression of Egr-1 in rat mesangial cells.
Sabuda-Widemann D; Grabensee B; Schwandt C; Blume C
Nephrol Dial Transplant; 2009 Jan; 24(1):52-61. PubMed ID: 18723570
[TBL] [Abstract][Full Text] [Related]
6. CCN3 is a novel endogenous PDGF-regulated inhibitor of glomerular cell proliferation.
van Roeyen CR; Eitner F; Scholl T; Boor P; Kunter U; Planque N; Gröne HJ; Bleau AM; Perbal B; Ostendorf T; Floege J
Kidney Int; 2008 Jan; 73(1):86-94. PubMed ID: 17914348
[TBL] [Abstract][Full Text] [Related]
7. Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis.
Nakamura H; Isaka Y; Tsujie M; Akagi Y; Sudo T; Ohno N; Imai E; Hori M
Kidney Int; 2001 Jun; 59(6):2134-45. PubMed ID: 11380815
[TBL] [Abstract][Full Text] [Related]
8. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
[TBL] [Abstract][Full Text] [Related]
9. The development of ternary nanoplexes for efficient small interfering RNA delivery.
Şalva E; Turan SÖ; Akbuğa J
Biol Pharm Bull; 2013; 36(12):1907-14. PubMed ID: 24432377
[TBL] [Abstract][Full Text] [Related]
10. RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats.
Chen SW; Zhang XR; Wang CZ; Chen WZ; Xie WF; Chen YX
Liver Int; 2008 Dec; 28(10):1446-57. PubMed ID: 18466260
[TBL] [Abstract][Full Text] [Related]
11. miR-34a regulates mesangial cell proliferation via the PDGFR-β/Ras-MAPK signaling pathway.
Chen D; Li Y; Mei Y; Geng W; Yang J; Hong Q; Feng Z; Cai G; Zhu H; Shi S; Bai XY; Chen X
Cell Mol Life Sci; 2014 Oct; 71(20):4027-42. PubMed ID: 24638095
[TBL] [Abstract][Full Text] [Related]
12. Fingolimod inhibits PDGF-B-induced migration of vascular smooth muscle cell by down-regulating the S1PR1/S1PR3 pathway.
Mousseau Y; Mollard S; Richard L; Nizou A; Faucher-Durand K; Cook-Moreau J; Qiu H; Baaj Y; Funalot B; Fourcade L; Sturtz FG
Biochimie; 2012 Dec; 94(12):2523-31. PubMed ID: 22828274
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of Egr-1 prevents mesangial cell hypercellularity in experimental nephritis.
Carl M; Akagi Y; Weidner S; Isaka Y; Imai E; Rupprecht HD
Kidney Int; 2003 Apr; 63(4):1302-12. PubMed ID: 12631347
[TBL] [Abstract][Full Text] [Related]
14. Gene expression of PDGF and PDGF receptor in various forms of glomerulonephritis.
Matsuda M; Shikata K; Makino H; Sugimoto H; Ota K; Akiyama K; Hirata K; Ota Z
Am J Nephrol; 1997; 17(1):25-31. PubMed ID: 9057949
[TBL] [Abstract][Full Text] [Related]
15. Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease.
van Roeyen CR; Eitner F; Martinkus S; Thieltges SR; Ostendorf T; Bokemeyer D; Lüscher B; Lüscher-Firzlaff JM; Floege J; Mertens PR
J Am Soc Nephrol; 2005 Oct; 16(10):2985-96. PubMed ID: 16093451
[TBL] [Abstract][Full Text] [Related]
16. Mesangial cell expression of proto-oncogene Ets-1 during progression of mesangioproliferative glomerulonephritis.
Raffetseder U; Wernert N; Ostendorf T; van Roeyen C; Rauen T; Behrens P; Floege J; Mertens PR
Kidney Int; 2004 Aug; 66(2):622-32. PubMed ID: 15253715
[TBL] [Abstract][Full Text] [Related]
17. Growth arrest-specific protein 1 is a novel endogenous inhibitor of glomerular cell activation and proliferation.
van Roeyen CR; Zok S; Pruessmeyer J; Boor P; Nagayama Y; Fleckenstein S; Cohen CD; Eitner F; Gröne HJ; Ostendorf T; Ludwig A; Floege J
Kidney Int; 2013 Feb; 83(2):251-63. PubMed ID: 23254899
[TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor receptor beta regulates migration and DNA synthesis in metanephric mesenchymal cells.
Arar M; Xu YC; Elshihabi I; Barnes JL; Choudhury GG; Abboud HE
J Biol Chem; 2000 Mar; 275(13):9527-33. PubMed ID: 10734101
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-9 regulates cardiac fibrosis by targeting PDGFR-β in rats.
Wang L; Ma L; Fan H; Yang Z; Li L; Wang H
J Physiol Biochem; 2016 Jun; 72(2):213-23. PubMed ID: 26896308
[TBL] [Abstract][Full Text] [Related]
20. HBV promotes the proliferation of hepatic stellate cells via the PDGF-B/PDGFR-β signaling pathway in vitro.
Bai Q; An J; Wu X; You H; Ma H; Liu T; Gao N; Jia J
Int J Mol Med; 2012 Dec; 30(6):1443-50. PubMed ID: 23042547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
